Skip to content
Jean-Simon Diallo
Ottawa biotech incubator gets $5.5M boost from federal government
An organization aimed at incubating Ottawa biotechnology startups says it’s poised to help several promising companies commercialize their products after securing a multimillion-dollar grant from
Virica Biotech’s viral vector-boosting technology gets $790K shot in the arm
While about three-quarters of Virica’s 50 customers are gene therapy producers, founder and CEO Jean-Simon Diallo says his firm’s technology also accelerates the production of
Virica Biotech joins forces with NRC in quest to create treatment for rare genetic disorder
Ottawa startup announced this week it’s landed $400,000 in federal government funding to help the National Research Council of Canada develop a gene therapy to
It’s in their genes: Virica Biotech partners with U.K. firm on cancer-fighting treatments
Ottawa firm inks deal to help Oxford Biomedica improve the yield and production efficiency of its next-generation gene therapies.
Company’s revenues have more than doubled in the past year, and CEO expects headcount to grow from 16 to at least 30 by next year
Officials seek to build up Ottawa’s burgeoning biotech sector
Local economic development agencies are doing their best to help give the city’s fledgling biotech and medical devices sector a leg up
Get our email newsletters
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.
The Latest
Video
OBJ360
Sponsored
Sponsored
The Ottawa Hospital Foundation’s Campaign to Create Tomorrow
The $500-million fundraising campaign is the largest in our city’s history. It will reshape the future of healthcare in Ottawa and beyond.
EXPERT BLOGS
How Emotional Intelligence Can Give Business Leaders a Competitive Edge
Purposeful Change Psychotherapy
